News

BioAlliance has presented its results on a new oral chemotherapy nanoparticle formulation at the AAPS (American Association of Pharmaceutical Scientists) annual meeting in Los Angeles. The company claims,

Merck Eprova has signed an exclusive license agreement with Isofol Medical of Sweden to utilise Merck Eprova’s proprietary folate compound Modufolin in oncology. The use of Modufolin is

Abbott has entered into an agreement to acquire the global rights to PanGenetics’ PG110, a fully humanised antibody to Nerve Growth Factor (NGF). The move would expand the

Bioniche Pharma has reported the acquisition of Duraclon (clonidine hydrochloride injection) and Methadone Hydrochloride Injection USP from Xanodyne Pharmaceuticals. The company said that Duraclon (clonidine hydrochloride injection) has

Bioo Scientific has launched a new division, Bioo Therapeutics, to leverage their drug delivery vehicles and experience in antibody and small molecule research. The company seeks to use

Novartis has put a halt on its research and development venture in India, said Daniel Vasella, CEO of the company. This action is reportedly a result of the

Novartis has launched Prevacid24HR (lansoprazole delayed-release capsules 15mg/acid reducer) over-the-counter in pharmacies and retail stores across the US to treat frequent heartburn. Prevacid24HR has received FDA approval in

Cequent Pharmaceuticals (Cequent) has filed an investigational new drug (IND) application with the FDA. CEQ508, an orally administered tkRNAi drug candidate, targets beta-catenin, a key oncogene implicated in

Immuno Solid-phase Allergy Chip, or ISAC, is a multi-array technology package designed to provide a detailed assessment of specific allergies as part of the initial patient assessment and